Experiment 636865
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Hypericum perforatum (CLUSIACEAE) |
| Citation | JOSEY,ES: TACKETT,RL:. (1999). ST.JOHN'S WORT: A NEW ALTERNATIVE FOR DEPRESSION?. 37(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | A DOUBLE-BLIND STUDY IN 135 PATIENTS FOCUSED ON THE EFFECTS OF ST.JOHN'S WORT VERSUS THOSE OF IMIPRAMINE IN THE TREATMENT OF DEPRESSION. IN A CRITIQUE OF THE ANALYSIS OF THIS STUDY. LINDE ET AL. REPORTS 63% OF THE PATIENTS RESPONDING FAVORABLY TO THE HYPERICUM, WHEREAS ONLY 54% RESPONDED TO THE IMIPRAMINE THERAPY. ALL RESPONDERS REPORTED FEWER SIDE-EFFECTS WITH THE HYPERICUM THERAPY (11.9% WITH HYPERICIN VERSUS 16.2% WITH IMIPRAMINE). THE MAJOR SIDE-EFFECTS MENTIONED INCLUDED DRY MOUTH AND DIZZINESS AND WERE SAID TO BE MILD IN THE HYPERICUM-TREATED GROUP. ALSO, FEWER PATIENTS TAKING HYPERICUM DROPPED OUT OF THE STUDY THAN DID THOSE PATIENTS TAKING IMIPRAMINE. THIS STUDY HAD A LONGER DURATION THAN THE ONE PERFORMED BY SOMMER AND HARRER, WITH A SIX-WEEK, RATHER THAN A FOUR-WEEK. A COMMERCIAL PRODUCT, JARSIN 300, WAS USED. |
| Dose amount | 900.0 MG |
| Number | 3 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | GIVEN TO BOTH SEXES |